MAY 13, 2020 3:44 PM PDT

Drug Targets Off Episodes of Parkinson

WRITTEN BY: Nouran Amin

A novel drug was approved by the FDA to target the “off” episodes of Parkinson disease. The drug is referred to as ‘Ongentys’ which is a catechol-o-methyltransferase (COMT) inhibitor that when combined with another drug improves treatment efficacy. In other words, Ongentys works with levodopa to increase more dopamine entry into the brain.

Learn more about Parkinson:

Dopamine is brain fuel that stimulates normal movements and decreases symptoms associated with Parkinson.

Learn more about dopamine:

Some adverse effects associated with Ongentys use includes abnormal dreams, headaches, sleep challenges, hallucinations, and low blood pressure. Although some complications, such as dyskinesia (involuntary movements), is related to levodopa boost rather than Ongentys alone.

Source: MichaelJFox.org

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
NOV 16, 2020
Drug Discovery & Development
A Change of Heart
NOV 16, 2020
A Change of Heart
For a long time cardiovascular issues related to the heart muscular wall have been addressed by therapeutics that target ...
DEC 21, 2020
Cancer
Examining the Bioactive Components of an Alga Against Cancer
DEC 21, 2020
Examining the Bioactive Components of an Alga Against Cancer
Many of today’s drugs come from vast libraries of synthetic compounds built by chemists for big pharma. This drug ...
DEC 22, 2020
Technology
New RNA Discovery Tool Accelerates Drug Discovery
DEC 22, 2020
New RNA Discovery Tool Accelerates Drug Discovery
Some diseases, such as metastatic breast cancer are known as “undruggable” or best described as unresponsive ...
DEC 25, 2020
Drug Discovery & Development
Class of Antibiotics May Target Resistant Bacteria
DEC 25, 2020
Class of Antibiotics May Target Resistant Bacteria
Researchers found a new class of antibiotics for combatting antimicrobial resistance (AMR). Learn more about antibiotic ...
JAN 24, 2021
Cannabis Sciences
Cannabis Compound CBD Shows Promise as Antibiotic
JAN 24, 2021
Cannabis Compound CBD Shows Promise as Antibiotic
Researchers from the University of Queensland, in collaboration with Botanix Pharmaceuticals Limited, have found that ca ...
Loading Comments...